Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.
2.
3.

Artificial escape from XCI by DNA methylation editing of the CDKL5 gene.

Halmai JANM, Deng P, Gonzalez CE, Coggins NB, Cameron D, Carter JL, Buchanan FKB, Waldo JJ, Lock SR, Anderson JD, O'Geen H, Segal DJ, Nolta J, Fink KD.

Nucleic Acids Res. 2020 Jan 11. pii: gkz1214. doi: 10.1093/nar/gkz1214. [Epub ahead of print]

PMID:
31925439
4.
5.

Effects of intravitreal injection of human CD34+ bone marrow stem cells in a murine model of diabetic retinopathy.

Yazdanyar A, Zhang P, Dolf C, Smit-McBride Z, Cary W, Nolta JA, Zawadzki RJ, Marsh-Armstrong N, Park SS.

Exp Eye Res. 2020 Jan;190:107865. doi: 10.1016/j.exer.2019.107865. Epub 2019 Nov 1.

PMID:
31682846
6.

Tunable hydrogels for mesenchymal stem cell delivery: Integrin-induced transcriptome alterations and hydrogel optimization for human wound healing.

Marusina AI, Merleev AA, Luna JI, Olney L, Haigh NE, Yoon D, Guo C, Ovadia EM, Shimoda M, Luxardi G, Boddu S, Lal NN, Takada Y, Lam KS, Liu R, Isseroff RR, Le S, Nolta JA, Kloxin AM, Maverakis E.

Stem Cells. 2020 Feb;38(2):231-245. doi: 10.1002/stem.3105. Epub 2019 Nov 23.

PMID:
31648388
7.

Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J, Phinney DG, Sensebe L.

Cytotherapy. 2019 Oct;21(10):1019-1024. doi: 10.1016/j.jcyt.2019.08.002. Epub 2019 Sep 13.

PMID:
31526643
8.

Preclinical translation of exosomes derived from mesenchymal stem/stromal cells.

Elahi FM, Farwell DG, Nolta JA, Anderson JD.

Stem Cells. 2020 Jan;38(1):15-21. doi: 10.1002/stem.3061. Epub 2019 Oct 1. Review.

9.

Follow the Tennis Ball Like a Golden Retriever.

Nolta JA.

Stem Cells Dev. 2019 Jun 1;28(11):708. doi: 10.1089/scd.2019.0077. Epub 2019 May 15. No abstract available.

PMID:
31090493
10.

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, Farwell G, Kuhn M, Nolta JA, Anderson JD.

Biochem Biophys Res Commun. 2019 May 14;512(4):729-735. doi: 10.1016/j.bbrc.2019.03.119. Epub 2019 Mar 26.

11.

Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells.

Gao K, Kumar P, Cortez-Toledo E, Hao D, Reynaga L, Rose M, Wang C, Farmer D, Nolta J, Zhou J, Zhou P, Wang A.

Stem Cell Res Ther. 2019 Jan 22;10(1):34. doi: 10.1186/s13287-019-1138-8.

12.

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion.

Yuan O, Lin C, Wagner J, Archard JA, Deng P, Halmai J, Bauer G, Fink KD, Fury B, Perotti NH, Walker JE, Pollock K, Apperson M, Butters J, Belafsky P, Farwell DG, Kuhn M, Nolta J, Anderson JD.

Stem Cells Dev. 2019 Mar 15;28(6):398-409. doi: 10.1089/scd.2018.0200. Epub 2019 Feb 26.

13.

Now More Than Ever: The Importance of Reporting Evidence-Based Science.

Nolta JA.

Stem Cells. 2019 Jan;37(1):4-5. doi: 10.1002/stem.2962. No abstract available.

14.

Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.

Cortez-Toledo E, Rose M, Agu E, Dahlenburg H, Yao W, Nolta JA, Zhou P.

Stem Cells Dev. 2019 Jan 15;28(2):114-119. doi: 10.1089/scd.2018.0090. Epub 2018 Dec 18.

15.

Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions.

Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA.

Transfusion. 2019 Feb;59(S1):893-897. doi: 10.1111/trf.14914. Epub 2018 Nov 1.

16.

Effects of Micronized Cartilage Matrix on Cartilage Repair in Osteochondral Lesions of the Talus.

Shieh AK, Singh SG, Nathe C, Lian E, Haudenschild DR, Nolta JA, Lee CA, Giza E, Kreulen CD.

Cartilage. 2018 Aug 29:1947603518796125. doi: 10.1177/1947603518796125. [Epub ahead of print]

PMID:
30156865
17.

Generation of human vascularized brain organoids.

Pham MT, Pollock KM, Rose MD, Cary WA, Stewart HR, Zhou P, Nolta JA, Waldau B.

Neuroreport. 2018 May 2;29(7):588-593. doi: 10.1097/WNR.0000000000001014.

18.

Research Leads to Approved Therapies in the New Era of Living Medicine.

Nolta JA.

Stem Cells. 2018 Jan;36(1):1-3. doi: 10.1002/stem.2748. No abstract available.

19.

Electrical Guidance of Human Stem Cells in the Rat Brain.

Feng JF, Liu J, Zhang L, Jiang JY, Russell M, Lyeth BG, Nolta JA, Zhao M.

Stem Cell Reports. 2017 Jul 11;9(1):177-189. doi: 10.1016/j.stemcr.2017.05.035. Epub 2017 Jun 29.

20.

Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia.

Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS.

Curr Eye Res. 2017 Oct;42(10):1358-1367. doi: 10.1080/02713683.2017.1319491. Epub 2017 Jun 21.

21.

Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia.

Kuhn MA, Black AB, Siddiqui MT, Nolta JA, Belafsky PC.

Laryngoscope. 2017 Oct;127(10):E359-E363. doi: 10.1002/lary.26666. Epub 2017 May 23.

PMID:
28543406
22.

Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N.

Pediatr Res. 2017 Sep;82(3):527-535. doi: 10.1038/pr.2017.74. Epub 2017 May 31.

23.

Concise Review: Stem Cells in Osteoimmunology.

Fierro FA, Nolta JA, Adamopoulos IE.

Stem Cells. 2017 Jun;35(6):1461-1467. doi: 10.1002/stem.2625. Epub 2017 May 2. Review.

24.

Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways.

Harding A, Cortez-Toledo E, Magner NL, Beegle JR, Coleal-Bergum DP, Hao D, Wang A, Nolta JA, Zhou P.

Stem Cells. 2017 Apr;35(4):909-919. doi: 10.1002/stem.2577. Epub 2017 Mar 1.

25.

Cutting Edge Advances in Stem Cell Biology and Therapy.

Nolta JA.

Stem Cells. 2017 Jan;35(1):1-2. doi: 10.1002/stem.2547. No abstract available.

26.

Advances in bone marrow stem cell therapy for retinal dysfunction.

Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA.

Prog Retin Eye Res. 2017 Jan;56:148-165. doi: 10.1016/j.preteyeres.2016.10.002. Epub 2016 Oct 23. Review.

27.

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia.

Beegle JR, Magner NL, Kalomoiris S, Harding A, Zhou P, Nacey C, White JL, Pepper K, Gruenloh W, Annett G, Nolta JA, Fierro FA.

Mol Ther Methods Clin Dev. 2016 Aug 24;3:16053. doi: 10.1038/mtm.2016.53. eCollection 2016.

28.

Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration.

Moisseiev E, Smit-McBride Z, Oltjen S, Zhang P, Zawadzki RJ, Motta M, Murphy CJ, Cary W, Annett G, Nolta JA, Park SS.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4125-35. doi: 10.1167/iovs.16-19252.

29.

Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.

Satake N, Duong C, Yoshida S, Oestergaard M, Chen C, Peralta R, Guo S, Seth PP, Li Y, Beckett L, Chung J, Nolta J, Nitin N, Tuscano JM.

Mol Med. 2016 Oct;22:632-642. doi: 10.2119/molmed.2015.00210. Epub 2016 Jul 22.

30.

Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells.

Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, Fink KD.

Neural Regen Res. 2016 May;11(5):702-5. doi: 10.4103/1673-5374.182682. Review.

31.

Engineered BDNF producing cells as a potential treatment for neurologic disease.

Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta JA.

Expert Opin Biol Ther. 2016 Aug;16(8):1025-33. doi: 10.1080/14712598.2016.1183641. Epub 2016 May 21. Review.

32.

"Next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic.

Nolta JA.

Transfusion. 2016 Apr;56(4):15S-7S. doi: 10.1111/trf.13564. No abstract available.

33.

Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells.

Kalomoiris S, Cicchetto AC, Lakatos K, Nolta JA, Fierro FA.

J Cell Biochem. 2016 Sep;117(9):2128-37. doi: 10.1002/jcb.25519. Epub 2016 Mar 8.

34.

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts.

Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA.

Cell Transplant. 2016;25(4):677-86. doi: 10.3727/096368916X690863. Epub 2016 Feb 4.

35.

Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.

Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Contreras Z, Hoon M, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, Hwang B, Mulligan MS, Lehtiö J, Nolta JA.

Stem Cells. 2016 Mar;34(3):601-13. doi: 10.1002/stem.2298. Epub 2016 Feb 19.

36.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA.

Mol Ther. 2016 May;24(5):965-77. doi: 10.1038/mt.2016.12. Epub 2016 Jan 14.

37.

BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells.

Jung Y, Nolta JA.

Curr Stem Cell Res Ther. 2016;11(2):131-40.

PMID:
26763885
38.

Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy.

Black AB, Dahlenburg H, Pepper K, Nacey C, Pontow S, Kuhn MA, Belafsky PC, Nolta JA.

Hum Gene Ther Methods. 2015 Dec;26(6):193-6. doi: 10.1089/hgtb.2015.100. Epub 2015 Nov 6.

39.

Companion animals: Translational scientist's new best friends.

Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL.

Sci Transl Med. 2015 Oct 7;7(308):308ps21. doi: 10.1126/scitranslmed.aaa9116. Review.

40.

Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs.

McMahill BG, Spriet M, Sisó S, Manzer MD, Mitchell G, McGee J, Garcia TC, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK.

Stem Cells Transl Med. 2015 Oct;4(10):1173-86. doi: 10.5966/sctm.2015-0018. Epub 2015 Aug 13.

41.

Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine.

Vapniarsky N, Arzi B, Hu JC, Nolta JA, Athanasiou KA.

Stem Cells Transl Med. 2015 Oct;4(10):1187-98. doi: 10.5966/sctm.2015-0084. Epub 2015 Aug 7. Review.

42.

Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA.

Regen Med. 2015;10(5):623-46. doi: 10.2217/rme.15.25. Review.

43.

Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols.

Lakatos K, Kalomoiris S, Merkely B, Nolta JA, Fierro FA.

J Cell Biochem. 2016 Feb;117(2):300-7. doi: 10.1002/jcb.25292.

PMID:
26212931
44.

Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor.

Sheu J, Beltzer J, Fury B, Wilczek K, Tobin S, Falconer D, Nolta J, Bauer G.

Mol Ther Methods Clin Dev. 2015 Jun 17;2:15020. doi: 10.1038/mtm.2015.20. eCollection 2015.

45.

Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery.

Cary WA, Hori CN, Pham MT, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta JA, Waldau B.

World Neurosurg. 2015 Nov;84(5):1256-66.e1. doi: 10.1016/j.wneu.2015.05.076. Epub 2015 Jun 11.

PMID:
26074438
46.

Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall.

Osborn SL, So M, Hambro S, Nolta JA, Kurzrock EA.

Tissue Eng Part A. 2015 Jun;21(11-12):1906-15. doi: 10.1089/ten.TEA.2014.0630. Epub 2015 Apr 22.

47.

Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo.

Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, Fierro FA.

Stem Cells. 2015 Jun;33(6):1818-28. doi: 10.1002/stem.1976. Epub 2015 May 11.

48.

Involvement of mesenchymal stem cells in cancer progression and metastases.

Chang AI, Schwertschkow AH, Nolta JA, Wu J.

Curr Cancer Drug Targets. 2015;15(2):88-98. Review.

PMID:
25619387
49.

Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.

Barisone GA, Satake N, Lewis C, Duong C, Chen C, Lam KS, Nolta J, Dίaz E.

Blood Cells Mol Dis. 2015 Apr;54(4):329-35. doi: 10.1016/j.bcmd.2014.12.002. Epub 2014 Dec 20.

50.

Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.

Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS.

Stem Cells. 2015 Mar;33(3):870-9. doi: 10.1002/stem.1919.

Supplemental Content

Support Center